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Abstract
The objective of the research was to identify resistant Mycobacterium tuberculosis strains and recognize their
molecular epidemiology and how they are disseminated in order to determine the cause and the effect of drug
resistance and the process of its development.
Materials and methods. Genomic deoxyribonucleic acid obtained from 37 drug-resistant Mycobacterium tu-
berculosis isolates were examined and fingerprinted by the IS6110- restriction fragment length polymorphism
method. The data obtained were then analyzed using SPSS statistics software.
Results. The mean patients’ age was 51 ± 15.5 years. There were 46% of male patients, 67.6% of the patients
from urban areas, 86.5% of Iranians, 21.6% of relapsed cases, 8.1% of human immunodeficiency virus-positive
patients, and 10.8% of the patients with a history of contact with tuberculosis patient. Based on IS6110 -
restriction fragment length polymorphism, 30 different genetic types were observed which indicated a significant
variation of this pathogen in Markazi province, Iran. The number of cluster genotypes was determined by 6
clusters; the number of unique types was 24. There were no relationships between age, gender, nationality,
residence, close contact with tuberculosis patients, recurrence of tuberculosis, positive human immunodeficiency
virus status and clustered or non-clustered strain genotype.
Conclusions. Considering the high genetic diversity in Mycobacterium tuberculosis strains, it can be concluded
that, based on IS6110 - restriction fragment length polymorphism, about 65% of cases occurred due to
reactivation, and 35% of the cases were due to recent transmission. The information obtained through the
molecular typing method can be very effective in future planning for tuberculosis control in Iran.
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Problem statement and analysis of
the latest research
Tuberculosis is an infectious disease, and about
1.7 billion people, 23% of the world’s population,
are estimated to have latent tuberculosis (TB) in-
fection and are thus at risk of developing active
TB disease during their lifetime. In 2017, there
were an estimated 10 million cases of TB globally;
about 1.3 million deaths among human immunodefi-
ciency virus (HIV) - negative people were caused by
TB; there were additional 300, 000 deaths from TB
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among HIV-positive people. Drug-resistant TB con-
tinues to be an important public health problem. Ac-
cording to the World Health Organization (WHO),
about 558, 000 people worldwide developed TB
that was resistant to rifampicin in 2017; 82% of
these cases were multidrug-resistant TB (MDR-TB).
Globally, in 3.5% of new TB cases and 18% of
previously treated cases, MDR TB was observed.
Among cases of MDR-TB in 2017, 8.5% were esti-
mated to have extensively drug-resistant TB (XDR-
TB). Due to the emergence and spread of drug resis-
tance, the WHO ranked the disease above acquired
immunodeficiency syndrome (AIDS) and hepatitis.
TB remains one of the 10 most communicable dis-
eases [1]. About 95% of all TB cases and 98% of
deaths from TB occur in developing countries. One
of the main factors of TB control is the identifica-
tion of infected people and a rapid detection of the
origin of infection. Therefore, the diagnosis of the
patients with active TB plays an important role in
controlling TB and its effective management. The
disease may result from the reactivation of latent
infection, or from recent infection and active trans-
mission. Therefore, the distinction between recent
infection and reactivation of infection in TB control
programs is of particular importance [2].
According to the WHO, the incidence of TB
in Iran in 2017 was reported to be about 14 per
100, 000 people, and the incidence of MDR-TB was
0.24 per 100, 000 people [1]. Racial and geographi-
cal diversity and socioeconomic differences of the
population affected the prevalence of TB in differ-
ent geographical regions of Iran. The WHO has
developed a standard short-course therapy for TB.
This therapy includes the treatment of new cases us-
ing isoniazid, rifampin, pyrazinamide, and ethambu-
tol for two months, followed by two-drug treatment
with rifampin and isoniazid [3]. Drug-resistant TB
was first discovered in 1943 and was followed by
the extensive and unpredictable use of rifampin.
MDR-TB was observed in 1990 being a leading
cause of morbidity worldwide. In 1993, the WHO
declared TB a ”global emergency” 1993 [2]. Multi-
drug resistance is defined as resistance to isoniazid
and rifampin. The problem of drug resistance is a
major threat to TB control and a major concern for
global health [4, 5].
Drug-resistant TB occurs when a genetic muta-
tion occurs in mycobacterium. In addition, defec-
tive treatment results in the degradation of suscep-
tible bacilli and, resistant strains survive, multiply,
and become dominant strains in the body. It should
be noted that in Iran, drug-resistant TB is an im-
portant health problem as well [6]. The analysis
of TB transmission and the tracing of infectious
resources requires the ability to differentiate be-
tween Mycobacterium tuberculosis species. Some
methods which, until now, have been based on the
study of phenotypic traits such as serotypes, bio-
types, or antimicrobial susceptibility, were used to
classify these species [7]. Molecular epidemiol-
ogy is used to better understand the status, spread,
and pathogenicity of diseases. Techniques such as
restriction fragment length polymorphism (RFLP)
are suggested to differentiate mycobacteria and de-
termine the characteristics of isolated species, and
in addition, this technique has been used success-
fully to prove laboratory cross-contamination and
is applicable to detect the occurrence of TB [8].
The objective of the research was to deter-
mine different drug-resistant strains of Mycobac-
terium tuberculosis, which are likely to be responsi-
ble for infections through recent person-to-person
transmissions or to identify strains indicating the
activation of latent infection in a person with TB
using IS6110-RFLP fingerprinting techniques.
1. Materials and Methods
This is a descriptive cross-sectional study that was
conducted on the patients over 3 years in Markazi
province in Iran. All the patients with smear posi-
tive pulmonary TB diagnosed by health centers and
candidates for anti-TB treatment were included in
the study.
The sample size was calculated based on statis-
tical estimation with a 95% confidence interval and
previous study [9] taking into account:
p = 0.23
q = 0.77
d = 0.135 n= Z
(1−α/2)2 × p×q÷d2
n = 37
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Thus, a total of 37 patients with drug resistance
were studied. This study was approved by the Arak
Medical University’s Ethics Council (code number:
93-110-72).
1.1 Sampling and culture
Sampling was carried out by a simple random
method and gradually completed over a 36-month
period. After receiving the patients’ consent, a ques-
tionnaire on demographic information and the re-
sults of sputum examination was completed by the
health experts. Then, sputum samples were taken
using the Kubica’s method by means of decontami-
nation and condensation. Concentrated suspensions
were cultured on the Lowenstein-Jensen media con-
taining glycerin and pyruvate and stored at 37◦ C
for 6-8 weeks. Then, biochemical tests (such as
Niacin test, Nitrate Reduction test, Heat Resistant
Catalase test, etc.) were used to diagnose Mycobac-
terium tuberculosis.
All these strains were cultured on the Lowenstein-
Jensen medium containing antibiotics and that with-
out antibiotics (as control). Also, the Mycobac-
terium tuberculosis strain H37Rv, which is suscep-
tible to all drugs, was used as a qualitative control.
To determine the susceptibility of isolated strains,
the proportional method was used according to the
WHO guidelines and the Clinical and Laboratory
Standards Institute (CLSI) [10, 11]. Drug suscepti-
bility was tested on the Lowenstein-Jensen medium
containing isoniazid – 0.2 mcg/ml, rifampicin –
40 mcg/ml, ethambutol – 2 mcg/ml, streptomycin –
4 mcg/ml. Pyrazinamide susceptibility testing was
not performed.
Thirty-seven isolates were found to be resistant
to at least one of the first-line drugs. Subsequently,
deoxyribonucleic acid (DNA) extracted from 37
isolates for genomic fingerprinting and polymor-
phism of resistant Mycobacterium tuberculosis was
studied.
1.2 IS6110-RFLP
To obtain the IS6110-RFLP pattern, DNA isolated
from bacterial culture was purified. Then, DNA was
digested with the Proteus vulgaris (Pvu) II enzymes
(0.9 to 10.9 kb) and the fragments of DNA were
separated on the agarose gel. To view the compo-
nents containing the IS6110, a peroxidase-labeled
probe containing complementary DNA of IS6110
was added to DNA hybridization buffer that was
subsequently poured on a nitrocellulose membrane.
Compounds produced by the Pvu II enzyme which
were hybridized with the IS6110 probe were de-
tected by a chemiluminescence reaction; the RFLP
pattern was detected on a light-sensitive film. Gel-
campair software was used to compare the finger-
prints.
2. Results
The mean patients’ age was 51 ± 15.5 years. There
were 46% of male patients, 67.6% of the patients
from urban areas, 86.5% of Iranians, 21.6% of re-
lapsed cases, 8.1% of HIV-positive patients, and
10.8% of the patients with a history of contact with
TB patients.
The number of copies of IS6110 in each of the
isolates was determined by the number of bands hy-
bridizing with the probe, and the number of copies
varied from zero to seventeen; therefore, the number
of copies of isolates was divided into four groups:
no copies; low copy number (1-2 copies); moderate
copy number (3-5 copies); high copy number (6-17
copies). The average number of IS6110 copies was
9; 5 samples had low copy number; 7 samples had
moderate copy number; 23 samples had high copy
number; 2 samples had no copies. Twenty-four
strains (64.9%) showed a unique pattern; six other
patterns (35.1%) were related to 13 patients.
Among the species studied, three MDR My-
cobacterium tuberculosis isolates were involved in
3 separate isolates in recent infections. The similar-
ity between strains was very low; and one MDR My-
cobacterium tuberculosis isolate and one non-MDR
Mycobacterium tuberculosis isolate belonging to
two Afghan refugee patients were similar to Iranian
patients, and the remaining isolates of Afghan pa-
tients had no similarity to Iranian patients. There
were found no strains belonging to the Beijing fam-
ily of strains. There were no relationships between
age, gender, nationality, residence, close contact
with TB patient, recurrence of TB, positive HIV
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Table 1. Risk factors associated with clustered and non-clustered cases among 37 patients with resistant
Mycobacterium tuberculosis strains in Iran (IS6110-RFLP)
Variable
Clustered strain
genotype
Non-clustered
strain genotype
Adjusted OR
(CI 95%)
p
13 (35%) 24 (65%)
Age
<45 years old 8 (21.6%) 12 (32.4%) 0.63
0.7307≥ 45 years old 5 (13.5%) 12 (32.4%) (0.16-2.47)
Gender
Males 6 (16.2%) 11 (29.7%) 0.98
0.6267
Females 7 (18.9%) 13 (35.1%) (0.26-3.82)
Type of patient
New case 12 (32.4%) 17 (45.9%) 0.2
0.2164
Recurrence 1 (2.7%) 7 (18.9%) (0.02-1.87)
Nationality
Iranian 11 (29.7%) 21 (56.8%) 1.27
0.5856
Afghan 2 (5.4%) 3 (8.1%) (0.18-8.78)
Residence
Urban 8 (21.6%) 17 (45.9%) 1.52
0.7161
Rural 5 (13.5%) 7 (18.9%) (0.37-6.30)
Close contact
with TB patient
Yes 3 (8.1%) 1 (2.7%) 0.15
0.1147
No 10 (27%) 23 (62.2%) (0.01-1.57)
HIV infection
Yes 1 (2.7%) 2 (5.4%) 1.09
0.7223
No 12 (32.4%) 22 (59.5%) (0.09-13.31)
status and clustered or non-clustered strain geno-
type (Table 1).
3. Discussion
Thirty genetic variants were detected by the IS6110-
RFLP method. There was observed a significant
variety of this pathogen in Markazi province. Con-
sequently, in this study, similar to other studies, ac-
tivated TB with more drug resistance occurred due
to reactivation of infection, and recent transmission
played a less important role. However, there were
observed some recent transmissions that should be
considered as a danger to the health system, espe-
cially the system dealing with TB.
The similarity of the genetic variants of My-
cobacterium tuberculosis isolated from Iranian and
Afghan patients in 2 cases and the similarity of
3 isolates indicated that the prolonged presence of
non-Iranian minorities in the country plays a certain
role in the transmission of strains with resistance to
Iranian citizens. In this group, there was found one
of the MDR isolates.
In other studies, conducted in Iran, there was a
wide genetic variation in Mycobacterium tuberculo-
sis strains, which suggested that TB affected people
of different origins. Therefore, reactivation of infec-
tion seems to play a greater role in the spread of TB.
In a study carried out in Tehran, among 292 strains
of Mycobacterium tuberculosis, 232 strains showed
a unique pattern indicating re-activation of infection
and 60 strains showed the same pattern indicating
the transfer and activation of these strains. Simi-
larly, in another study conducted in West Azerbaijan
Province and East Azerbaijan Province, among 154
strains isolated from the patients, 69.5% of them
had a unique RFLP pattern. Therefore, reactivation
of infection was found to play a greater role in the
epidemiology of TB in these areas. It is estimated
that 90 % of TB cases in developed countries are
due to reactivation of the disease at an advanced
age and transmission plays a less important role in
infection [12, 13, 14].
In another study, the prevalence of TB among
Afghan refugees living in Tehran was determined by
genotyping IS6110-RFLP. Among 60 immigrant pa-
tients, only 2 Afghan refugees were diagnosed with
the disease in Tehran; therefore, the transmission of
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the disease from Afghan refugees to Iranian people
was unusual [15]. While in our study, there was a
certain similarity between two Afghan isolates and
Iranian isolates, which could be attributed to the
transmission of the disease and the presence of epi-
demic isolates. This study did not fully investigate
the social relationships between these patients, and
it was impossible to determine the index case. The
molecular technique used in this study was selected
according to the WHO method and provided the
highest distinction for Mycobacterium tuberculo-
sis polymorphism [16]. High patients’ age and the
presence of a wide range of genetic diversity, de-
spite the relatively limited number of isolates, could
confirm the role of reactivation of old infections at
the onset of the disease as compared to transmission
of infection between the patients.
4. Conclusions
In our study, there was observed a transmission of
resistant Mycobacterium tuberculosis strains in the
study population, indicating the lack of timely iden-
tification of the patients and their role in transmis-
sion of the disease in the community. Considering
the high genetic diversity in Mycobacterium tuber-
culosis strains, it can be concluded that based on
IS6110-RFLP about 65% of cases occurred due to
reactivation, and 35% of the cases were due to re-
cent transmission. A similar pattern of antibiogram
in the patients with similar strains suggested exten-
sive transmission of a single strain in the commu-
nity. It can be assumed that the strain was initially
susceptible, and as a result of transfer from one
host to another host (for example due to failure
of treatment in the patients), it turned into a non-
MDR strain and eventually became MDR strain.
The molecular typing method of Mycobacterium tu-
berculosis strains can be very effective in future
planning for TB control in Iran. Considering the
importance of drug resistance in TB, the necessity
of creating and expanding the ability to detect resis-
tance, including the use of rapid methods such as
polymerase chain reaction, is inevitable and neces-
sary in all provinces of the country.
5. Prospects of Further
Researches
This study was carried out with a relatively small
sample of the patients. To confirm the obtained
findings, it is necessary to study a larger sample of
the patients.
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